4 Merger and Acquisitions Stocks to Catch Up On

Analogic Corporation (NASDAQ:ALOG): Closing price $74.60

Analogic has agreed to purchase the privately-held Ultrasonix Medical Corporation, which is based in Vancouver, at a cash price of $83 million. Ultrasonix provides advanced ultrasound systems for point-of-care and general imaging applications, with more than 5,000 systems installed globally. The buyer enables worldwide medical imaging and aviation security tech. The transaction should close in late February.


Barrick Gold Corporation (NYSE:ABX) Closing price $33.51

The Canadian miner Barrick Gold terminates discussions about divesting an interest in majority-owned African Barrick Gold to a Chinese buyer,  ending the hope of a potential $3 billion deal for the underperforming division. The company holds a 74-percent stake in the  London-listed African Barrick, and had reported in August it was in early-stage negotiations with state-owned China National Gold about the possible sale of all or part of its stake.


Are these stocks a buy or a sell? Let us help you decide.  Check out our Wall St. Cheat Sheet Stock Picker Newsletter now>>

Acadia Healthcare Company (ACHC): Closing price $24.94

On Tuesday, Acadia reported its acquisition of Greenleaf Center, a 50-bed acute inpatient psychiatric facility in Valdosta, Georgia, in a transaction that was finalized January 1st, from South Georgia Medical Center, which is a non-profit health system. The Chairman and Chief Executive Officer of Acadia, Joey Jacobs, expects that, with annual revenues of about $7 million, this facility will have an accretive impact on the firm’s 2013 earnings per share.


Sanofi-Aventis (NYSE:SNY): Closing price $48.58

Sanofi announced that its United States Consumer Healthcare Division, Chattem, has finalized its purchase of the global rights to the Rolaids brand from McNeil Consumer Healthcare Division of McNEIL-PPC. Chief Executive Zan Guerry of Chattem commented that “The addition of Rolaids represents a rare opportunity to obtain an iconic brand that we believe will respond positively to our proven approach of growing brands through innovation and advertising. We are primed to leverage the Rolaids market opportunity to drive incremental growth and take the brand to a new level.”


Don’t Miss: Should Vodafone Take This Deal?